Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:815315.
doi: 10.1155/2012/815315. Epub 2012 Apr 5.

Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence

Affiliations

Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence

Cali F Bartholomeusz et al. Schizophr Res Treatment. 2012.

Abstract

Improving functional outcome, in addition to alleviating psychotic symptoms, is now a major treatment objective in schizophrenia research. Given the large body of evidence suggesting pharmacological treatments generally have minimal effects on indices of functioning, research has turned to psychosocial rehabilitation programs. Among these, neurocognitive and social cognitive interventions are at the forefront of this field and are argued to target core deficits inherent to the schizophrenia illness. However, to date, research trials have primarily focused on chronic schizophrenia populations, neglecting the early psychosis groups who are often as severely impaired in social and occupational functioning. This theoretical paper will outline the rationale for investigating adjunctive cognitive-based interventions in the early phases of psychotic illness, critically examine the current approach strategies used in these interventions, and assess the evidence supporting certain training programs for improving functional outcome in early psychosis. Potential pathways for future research will be discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Buchanan RW, Davis M, Goff D, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin. 2005;31(1):5–19. - PubMed
    1. Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophrenia Bulletin. 2009;35(2):300–306. - PMC - PubMed
    1. Birchwood M, Todd P, Jackson C. Early intervention in psychosis: the critical period hypothesis. British Journal of Psychiatry. 1998;172(33):53–59. - PubMed
    1. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience. 2000;250(6):274–285. - PubMed
    1. Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-Month follow up of a high-risk (“prodromal”) group. Schizophrenia Research. 2003;60(1):21–32. - PubMed

LinkOut - more resources